ADAR1 Capital Management reports $117,700 InMed Pharma common share purchase - INM News | RalliesADAR1 Capital Management reports $117,700 InMed Pharma common share purchase
I
INM• ADAR1 Capital Management increases indirect stake in InMed Pharmaceuticals
- ADAR1 Capital Management lifted its indirect stake in InMed Pharmaceuticals to 892,101 common shares through open-market purchases.
- Daniel Schneeberger, manager, was listed as an indirect beneficial owner through funds managed by ADAR1.
- Purchases were reported at weighted-average prices around $1.29 per share.
LAMR
•
